Page 48 - Read Online

14. Pestalozzi BC, Brignoli S. Trastuzumab in CSF. J Clin Oncol 30. Saunus JM, Quinn MC, Patch AM, Pearson JV, Bailey PJ, Nones
2000;18:2349-51. K, McCart Reed AE, Miller D, Wilson PJ, Al-Ejeh F, Mariasegaram
15. Bria E, Cuppone F, Fornier M, Nistico C, Carlini P, Milella M, M, Lau Q, Withers T, Jeffree RL, Reid LE, Da Silva L, Matsika A,
Sperduti I, Terzoli E, Cognetti F, Giannarelli D. Cardiotoxicity and Niland CM, Cummings MC, Bruxner TJ, Christ AN, Harliwong I,
incidence of brain metastases after adjuvant trastuzumab for early Idrisoglu S, Manning S, Nourse C, Nourbakhsh E, Wani S, Anderson
breast cancer: the dark side of the moon? A meta-analysis of the MJ, Fink JL, Holmes O, Kazakoff S, Leonard C, Newell F, Taylor D,
randomized trials. Breast Cancer Res Treat 2008;109:231-9. Waddell N, Wood S, Xu Q, Kassahn KS, Narayanan V, Taib NA, Teo
16. Chamberlain MC. Neoplastic meningitis. Curr Neurol Neurosci Rep SH, Chow YP, kConFab, Jat PS, Brandner S, Flanagan AM, Khanna
2008;8:249-58. KK, Chenevix-Trench G, Grimmond SM, Simpson PT, Waddell
17. Chamberlain MC. Neoplastic meningitis and metastatic epidural spinal N, Lakhani SR. Integrated genomic and transcriptomic analysis of
cord compression. Hematol Oncol Clin North Am 2012;26:917-31. human brain metastases identifies alterations of potential clinical
18. Winkler F. The brain metastatic niche. J Mol Med 2015;93:1213-20. significance. J Pathol 2015;237:363-78.
19. Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WE, 31. El-Deiry WS, Vijayvergia N, Xiu J, Scicchitano A, Lim B, Yee NS,
Goldbrunner R, Herms J, Winkler F. Real-time imaging reveals the Harvey HA, Gatalica Z, Reddy S. Molecular profiling of 6,892
single steps of brain metastasis formation. Nat Med 2010;16:116-22. colorectal cancer samples suggests different possible treatment options
20. Kodack DP, Chung E, Yamashita H, Incio J, Duyverman AM, Song Y, specific to metastatic sites. Cancer Biol Ther 2015;16:1726-37.
Farrar CT, Huang Y, Ager E, Kamoun W, Goel S, Snuderl M, Lussiez 32. Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG,
A, Hiddingh L, Mahmood S, Tannous BA, Eichler AF, Fukumura D, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de
Engelman JA, Jain RK. Combined targeting of HER2 and VEGFR2 Vries EG, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey
for effective treatment of HER2-amplified breast cancer brain ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti
metastases. Proc Natl Acad Sci U S A 2012;109:E3119-27. R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY. Response
21. Fidler IJ, Balasubramanian K, Lin Q, Kim SW, Kim SJ. The brain assessment criteria for brain metastases: proposal from the RANO
microenvironment and cancer metastasis. Mol Cells 2010;30:93-8. group. Lancet Oncol 2015;16:e270-8.
22. Park ES, Kim SJ, Kim SW, Yoon SL, Leem SH, Kim SB, Kim SM, 33. Okada H, Weller M, Huang R, Finocchiaro G, Gilbert MR, Wick W,
Park YY, Cheong JH, Woo HG, Mills GB, Fidler IJ, Lee JS. Cross- Ellingson BM, Hashimoto N, Pollack IF, Brandes AA, Franceschi
species hybridization of microarrays for studying tumor transcriptome E, Herold-Mende C, Nayak L, Panigrahy A, Pope WB, Prins R,
of brain metastasis. Proc Natl Acad Sci U S A 2011;108:17456-61. Sampson JH, Wen PY, Reardon DA. Immunotherapy response
23. Zhang L, Zhang S, Yao J, Lowery FJ, Zhang Q, Huang WC, Li P, Li assessment in neuro-oncology: a report of the RANO working group.
M, Wang X, Zhang C, Wang H, Ellis K, Cheerathodi M, McCarty JH, Lancet Oncol 2015;16:e534-42.
Palmieri D, Saunus J, Lakhani S, Huang S, Sahin AA, Aldape KD, 34. Kang TW, Kim ST, Byun HS, Jeon P, Kim K, Kim H, Lee JI.
Steeg PS, Yu D. Microenvironment-induced PTEN loss by exosomal Morphological and functional MRI, MRS, perfusion and diffusion
microRNA primes brain metastasis outgrowth. Nature 2015;527:100-4. changes after radiosurgery of brain metastasis. Eur J Radiol
24. Galon J, Mlecnik B, Bindea G, Angell HK, Berger A, Lagorce C, 2009;72:370-80.
Lugli A, Zlobec I, Hartmann A, Bifulco C, Nagtegaal ID, Palmqvist 35. Hoefnagels FW, Lagerwaard FJ, Sanchez E, Haasbeek CJ, Knol
R, Masucci GV, Botti G, Tatangelo F, Delrio P, Maio M, Laghi L, DL, Slotman BJ, Vandertop WP. Radiological progression of
Grizzi F, Asslaber M, D’Arrigo C, Vidal-Vanaclocha F, Zavadova E, cerebral metastases after radiosurgery: assessment of perfusion
Chouchane L, Ohashi PS, Hafezi-Bakhtiari S, Wouters BG, Roehrl MRI for differentiating between necrosis and recurrence. J Neurol
M, Nguyen L, Kawakami Y, Hazama S, Okuno K, Ogino S, Gibbs P, 2009;256:878-87.
Waring P, Sato N, Torigoe T, Itoh K, Patel PS, Shukla SN, Wang Y, 36. Kruger S, Mottaghy FM, Buck AK, Maschke S, Kley H, Frechen
Kopetz S, Sinicrope FA, Scripcariu V, Ascierto PA, Marincola FM, D, Wibmer T, Reske SN, Pauls S. Brain metastasis in lung cancer.
Fox BA, Pagès F. Towards the introduction of the ‘Immunoscore’ in Comparison of cerebral MRI and 18F-FDG-PET/CT for diagnosis in
the classification of malignant tumours. J Pathol 2014;232:199-209. the initial staging. Nuklearmedizin 2011;50:101-6.
25. Li W, Graeber MB. The molecular profile of microglia under the 37. Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S,
influence of glioma. Neuro Oncol 2012;14:958-78. Takami T, Ohata K. Diagnostic accuracy of 11C-methionine PET for
26. Bienkowski M, Preusser M. Prognostic role of tumour-infiltrating differentiation of recurrent brain tumors from radiation necrosis after
inflammatory cells in brain tumours: literature review. Curr Opin radiotherapy. J Nucl Med 2008;49:694-9.
Neurol 2015;28:647-58. 38. Grosu AL, Astner ST, Riedel E, Nieder C, Wiedenmann N,
27. Szulzewsky F, Pelz A, Feng X, Synowitz M, Markovic D, Langmann Heinemann F, Schwaiger M, Molls M, Wester HJ, Weber WA. An
T, Holtman IR, Wang X, Eggen BJ, Boddeke HW, Hambardzumyan D, interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine
Wolf SA, Kettenmann H. Glioma-associated microglia/macrophages (FET)- and L-[methyl-11C]methionine (MET)-PET in patients
display an expression profile different from M1 and M2 polarization with brain gliomas and metastases. Int J Radiat Oncol Biol Phys
and highly express Gpnmb and Spp1. PLoS One 2015;10:e0116644. 2011;81:1049-58.
28. Niessner H, Forschner A, Klumpp B, Honegger JB, Witte M, 39. Connell JJ, Chatain G, Cornelissen B, Vallis KA, Hamilton A,
Bornemann A, Dummer R, Adam A, Bauer J, Tabatabai G, Flaherty Seymour L, Anthony DC, Sibson NR. Selective permeabilization
K, Sinnberg T, Beck D, Leiter U, Mauch C, Roesch A, Weide B, of the blood-brain barrier at sites of metastasis. J Natl Cancer Inst
Eigentler T, Schadendorf D, Garbe C, Kulms D, Quintanilla-Martinez 2013;105:1634-43.
L, Meier F. Targeting hyperactivation of the AKT survival pathway to 40. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T,
overcome therapy resistance of melanoma brain metastases. Cancer McKenna WG, Byhardt R. Recursive partitioning analysis (RPA)
Med 2013;2:76-85. of prognostic factors in three Radiation Therapy Oncology Group
29. Chen G, Chakravarti N, Aardalen K, Lazar AJ, Tetzlaff MT, (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys
Wubbenhorst B, Kim SB, Kopetz S, Ledoux AA, Gopal YN, Pereira 1997;37:745-51.
CG, Deng W, Lee JS, Nathanson KL, Aldape KD, Prieto VG, Stuart 41. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new
D, Davies MA. Molecular profiling of patient-matched brain and prognostic index and comparison to three other indices for patients
extracranial melanoma metastases implicates the PI3K pathway as a with brain metastases: an analysis of 1,960 patients in the RTOG
therapeutic target. Clin Cancer Res 2014;20:5537-46. database. Int J Radiat Oncol Biol Phys 2008;70:510-4.

172
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ May 20, 2016 ¦